COA At-a-Glance
Evidence of cognitive interviewing of draft instrument in target patient population
Evidence of internal consistency
Evidence of test-retest or inter-rater reliability
Evidence of concurrent validity
Evidence of known-groups validity
Evidence of ability to detect change over time
Evidence of responder thresholds
Inclusion of the COA in product labelling
- Overview
- Content Validity
- Reliability
- Validity
- Ability to Detect Change
- Responder Thresholds
- Reference(s) of development / validation
- Other references
- Inclusion of the COA in product labelling
- Inclusion of the COA in product labelling (agency, drug, drug approval date, COA results) from PROLABELS search
- Existence of Scoring / Interpretation / User Manual
- Original language and translations
- References of translations
- Authors and contact information
- Condition of use: copyright
- Website
- Review copy
Overview
Instrument Name: Patient-Reported Outcomes Information System Pediatric Short Form v1.0 Sleep Disturbance 4a
Abbreviation: PROMIS Pediatric SF4 v1.0 SD
Points for Consideration:
None
Description of Tool:
The PROMIS Pediatric Short Form v1.0 Sleep Disturbance 4a is a 4-item PRO developed to assess sleep disturbance in children aged 8-17 years. Respondents are asked to rate the items on a 5-level scale "Never", "Rarely", "Sometimes", "Often" to "Always". Higher scores indicate greater sleep disturbance.
Other Related Tools (if applicable):
PROMIS Pediatric Bank v1.0 – Sleep Disturbance 8a
PROMIS Parent Proxy Bank v1.0 – Sleep Disturbance
PROMIS Parent Proxy Short Form v1.0 – Sleep Disturbance 8a
PROMIS Parent Proxy Short Form v1.0 – Sleep Disturbance 4a
PROMIS Early Childhood ParentReport Short Form v1.0 - Sleep Problems - Disturbance 4a
Differences between PROMIS measures can be found here: https://www.healthmeasures.net/images/PROMIS/Differences_Between_PROMIS_Measures/PROMIS_Sleep_Measure_Differences_05Dec2023.pdf
Minimum Qualification Required by COA Administrator: No degree requirement
Comment:
None
Year: 2018
Objective of Development:
To assess sleep disturbance
Population of Development: Age range (therapeutic indication):
Age range: 8-17 (Dyssomnias; Children without diagnosed sleep problem; Chronic kidney disease)
Pediatric Population(s) in which COA has been used:
None identified
COA type: PRO
Number of Items 4
Mode of Administration: Self-administered
Data Collection Mode: Paper and pen or digital administration
Time for Completion: No information
Response Scales: 5-point Likert scale ranging from 1 to 5: 1="Never", 2="Rarely", 3="Sometimes", 4="Often", 5="Always"
Summary of Scoring:
Available scores:
The PROMIS measures use a T-score metric in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population.
Raw Summed Score (4-20)
T-Score (38.8-79.1)
Standard error (SE) on T-score metric (-1.12-2.91)
Weighting: No
Score Interpretation: Higher score=Greater sleep disturbance
Content Validity
Evidence of Literature Review: None identified
Evidence of Instrument Review: Yes
Evidence of Clinical or Expert Input: Yes
Evidence of concept elicitation in target patient population: Yes
Evidence of a Saturation Grid: Yes
Evidence for Selection of Data Collection Method: Yes
Recall/Observation Period: Past 7-days
Evidence for Selection of Reponse Options: None identified
Evidence of cognitive interviewing of draft instrument in target patient population: Yes
Evidence of Preliminary Scoring of Items and Domains: None identified
Evidence related to respondent and administrator burden: None identified
Evidence of a Conceptual Framework: Yes
Evidence of an item-tracking matrix: Yes
Evidence related to item selection: None identified
Evidence of re-testing the final version: Yes
Reliability
Internal consistency (Cronbach's alpha): None identified
Evidence of internal consistency: None identified
Test-retest Reliability (ICC):
None identified
Inter-rater/ inter-interviewer reliability (kappa):
None identified
Evidence of test-retest or inter-rater reliability: None identified
Validity
Concurrent validity (convergent, divergent):
None identified
Known-group validity:
None identified
Evidence of Translatability Assessment: Yes
Evidence related to missing data: None identified
Evidence for Selection of Recall Period: None identified
Evidence of Administration Instructions and Training Provided: None identified
Evidence of concurrent validity: None identified
Evidence of known-groups validity: None identified
Evidence of ability to detect change over time: None identified
Ability to Detect Change
Ability to detect change (Responsiveness):
None identified
Responder Thresholds
Responder Thresholds:
None identified
Evidence of responder thresholds: None identified
Reference(s) of development / validation
Bevans, K. B., Meltzer, L. J., De La Motte, A., Kratchman, A., Viél, D., & Forrest, C. B. (2019). Qualitative Development and Content Validation of the PROMIS Pediatric Sleep Health Items. Behavioral sleep medicine, 17(5), 657–671. Full Text Article: https://pubmed.ncbi.nlm.nih.gov/29693445/
Other references
Differences between PROMIS measures: https://www.healthmeasures.net/images/PROMIS/Differences_Between_PROMIS_Measures/PROMIS_Sleep_Measure_Differences_05Dec2023.pdf
Scoring instructions: https://www.healthmeasures.net/administrator/components/com_instruments/uploads/PROMIS%20Sleep%20Scoring%20Manual_05Dec2023.pdf
Translations: https://www.healthmeasures.net/explore-measurement-systems/promis/intro-to-promis/available-translations
Inclusion of the COA in product labelling
None identified
Inclusion of the COA in product labelling (agency, drug, drug approval date, COA results) from PROLABELS search
None identified
Existence of Scoring / Interpretation / User Manual
Yes
Original language and translations
Original language: English
Translations found on Health measures website:
Spanish
Arabic
Italian
French
Traditional Chinese
German
Hebrew
Norwegian
Turkish
Dutch-Flemish
Polish
Portuguese
Japanese
Estonian
Lithuanian
Slovak
Bulgarian
Croatian
Greek
Latvian
Malay
Korean
Czech
Hungarian
Swedish
Simplified Chinese (Mandarin)
Russian
Serbian
Finnish
Bosnian
Slovene
Translations may be requested by contacting: translations@healthmeasures.net.
References of translations
None identified
Condition of use: copyright
© 2008-2018 PROMIS Health Organization (PHO) This material can be reproduced without permission by clinicians for use with their own patients. Any other use, including electronic use, requires written permission of the PHO.
Measures can be obtained here: https://www.healthmeasures.net/index.php?Itemid=992)
- Paper-based measures are available in PDF form.
- PROMIS measures are available for digital administration (Computer Adaptive Tests [CATs]. short forms and profiles)
- Electronic administration of the measures for other purposes or by commercial users require HealthMeasures Electronic Administration Permission (HEAP), which includes a permission letter and screenshot review. Single research studies by non-commercial users are exempt from the HEAP requirement.
HEAP fees (charged for the review and approval process):
- Paper administration of English or Spanish measure: free
- Non-commercial electronic administration of English or Spanish measure for research: free
- Non-commercial use of existing measures: $550 per measure for study duration or 3-year term.
- Commercial use of existing measures: $700 per measure for study duration or 3-year term.
- Non-commercial use of custom measures: $700 per measure for study duration or 3-year term.
- Commercial use of custom measures: $850 per measure for study duration or 3-year term.
- Commercial use of all non-English translated measures: by quote.
More information can be found here: https://www.healthmeasures.net/explore-measurement-systems/promis/obtain-administer-measures
Website
https://www.healthmeasures.net/
Review copy
https://www.healthmeasures.net/